chronic myelomonocytic leukemia

SHANGHAI, June 23, 2026 Mabwell announced that China’s National Medical Products Administration (NMPA) has granted Investigational New Drug (IND)...

BOSTON, Mass., May 27, 2026 Solu Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast...